Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Innovative Pharmaceutical Biotech ( (HK:0399) ) has shared an announcement.
Starcoin Group Limited announced its unaudited interim results for the six months ending September 30, 2025, reporting a significant loss of HK$119.3 million compared to a profit of HK$100.9 million in the previous year. The company’s financial performance was impacted by increased administrative and research expenses, alongside substantial finance costs, reflecting challenges in its operational and financial strategies.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, operates in the pharmaceutical and biotechnology industry. The company focuses on developing innovative biotech solutions and is incorporated in the Cayman Islands with operations continued in Bermuda.
Average Trading Volume: 22,822,188
Technical Sentiment Signal: Sell
Current Market Cap: HK$171.4M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.